Porras-Quesada, PGonzalez-Cabezuelo, J MSanchez-Conde, VPuche-Sanz, IArenas-Rodriguez, VGarcia-Lopez, CFlores-Martin, J FMolina-Hernandez, J MAlvarez-Cubero, M JMartinez-Gonzalez, L JVazquez-Alonso, F2023-05-032023-05-032021-11-29Porras-Quesada P, González-Cabezuelo JM, Sánchez-Conde V, Puche-Sanz I, Arenas-Rodríguez V, García-López C, et al. Role of IGF2 in the Study of Development and Evolution of Prostate Cancer. Front Genet. 2022 Jan 4;12:740641.1664-8021http://hdl.handle.net/10668/20572Prostate Cancer (PC) is commonly known as one of the most frequent tumors among males. A significant problem of this tumor is that in early stages most of the cases course as indolent forms, so an active surveillance will anticipate the appearance of aggressive stages. One of the main strategies in medical and biomedical research is to find non-invasive biomarkers for improving monitoring and performing a more precise follow-up of diseases like PC. Here we report the relevant role of IGF2 and miR-93-5p as non-invasive biomarker for PC. This event could improve current medical strategies in PC.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/IGF2biomarkerexpression patternsmiR-93-5pmiRNAprecision medicineprostate cancerMaleFollow-Up StudiesWatchful WaitingProstatic NeoplasmsBiomarkersMicroRNAsBiomedical Researchmesresearch article35095996open accessBiomarcadoresEspera vigilanteEstudios de seguimientoMasculinoMicroARNsNeoplasias de la próstata10.3389/fgene.2021.740641PMC8790605https://www.frontiersin.org/articles/10.3389/fgene.2021.740641/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790605/pdf